Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.

Paubelle E, Zylbersztejn F, Maciel TT, Carvalho C, Mupo A, Cheok M, Lieben L, Sujobert P, Decroocq J, Yokoyama A, Asnafi V, Macintyre E, Tamburini J, Bardet V, Castaigne S, Preudhomme C, Dombret H, Carmeliet G, Bouscary D, Ginzburg YZ, de Thé H, Benhamou M, Monteiro RC, Vassiliou GS, Hermine O, Moura IC.

Cell Rep. 2020 Jan 21;30(3):739-754.e4. doi: 10.1016/j.celrep.2019.12.055.

2.

Innate immune cells, major protagonists of sickle cell disease pathophysiology.

Allali S, Maciel TT, Hermine O, de Montalembert M.

Haematologica. 2020 Jan 31;105(2):273-283. doi: 10.3324/haematol.2019.229989. Print 2020. Review.

3.

Erdheim-Chester Disease: a Concise Review.

Papo M, Emile JF, Maciel TT, Bay P, Baber A, Hermine O, Amoura Z, Haroche J.

Curr Rheumatol Rep. 2019 Dec 5;21(12):66. doi: 10.1007/s11926-019-0865-2. Review.

PMID:
31807955
4.

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.

Guillem F, Dussiot M, Colin E, Suriyun T, Arlet JB, Goudin N, Marcion G, Seigneuric R, Causse S, Gonin P, Gastou M, Deloger M, Rossignol J, Lamarque M, Bellaid Choucair Z, Gautier EF, Ducamp S, Vandekerckhove J, Moura IC, Maciel TT, Garrido C, An X, Mayeux P, Mohandas N, Courtois G, Hermine O.

Haematologica. 2019 Nov 21. pii: haematol.2018.210054. doi: 10.3324/haematol.2018.210054. [Epub ahead of print]

5.

Pest Control Potential of Social Wasps in Small Farms and Urban Gardens.

Prezoto F, Maciel TT, Detoni M, Mayorquin AZ, Barbosa BC.

Insects. 2019 Jun 28;10(7). pii: E192. doi: 10.3390/insects10070192.

6.

Innate-like T cells in children with sickle cell disease.

Allali S, Dietrich C, Machavoine F, Rignault-Bricard R, Brousse V, de Montalembert M, Hermine O, Maciel TT, Leite-de-Moraes M.

PLoS One. 2019 Jun 28;14(6):e0219047. doi: 10.1371/journal.pone.0219047. eCollection 2019.

7.

A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.

McArthur JG, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J, Nguyen P, Prachikova A, Abdulla F, Vercellotti GM, Hermine O, Edwards D, Ribeil JA, Belcher JD, Maciel TT.

Haematologica. 2019 May 30. pii: haematol.2018.213462. doi: 10.3324/haematol.2018.213462. [Epub ahead of print]

8.

Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications.

Flores C, Fouquet G, Moura IC, Maciel TT, Hermine O.

Front Immunol. 2019 Mar 28;10:588. doi: 10.3389/fimmu.2019.00588. eCollection 2019. Review.

9.

Plasma histamine elevation in a large cohort of sickle cell disease patients.

Allali S, Lionnet F, Mattioni S, Callebert J, Stankovic Stojanovic K, Bachmeyer C, Arlet JB, Brousse V, de Montalembert M, Chalumeau M, Grateau G, Maciel TT, Launay JM, Hermine O, Georgin-Lavialle S.

Br J Haematol. 2019 Jul;186(1):125-129. doi: 10.1111/bjh.15900. Epub 2019 Mar 28.

PMID:
30924132
10.

Serum Iron Protects from Renal Postischemic Injury.

Vaugier C, Amano MT, Chemouny JM, Dussiot M, Berrou C, Matignon M, Ben Mkaddem S, Wang PHM, Fricot A, Maciel TT, Grapton D, Mathieu JRR, Beaumont C, Peraldi MN, Peyssonnaux C, Mesnard L, Daugas E, Vrtovsnik F, Monteiro RC, Hermine O, Ginzburg YZ, Benhamou M, Camara NOS, Flamant M, Moura IC.

J Am Soc Nephrol. 2017 Dec;28(12):3605-3615. doi: 10.1681/ASN.2016080926. Epub 2017 Aug 7.

11.

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.

Poulain L, Sujobert P, Zylbersztejn F, Barreau S, Stuani L, Lambert M, Palama TL, Chesnais V, Birsen R, Vergez F, Farge T, Chenevier-Gobeaux C, Fraisse M, Bouillaud F, Debeissat C, Herault O, Récher C, Lacombe C, Fontenay M, Mayeux P, Maciel TT, Portais JC, Sarry JE, Tamburini J, Bouscary D, Chapuis N.

Leukemia. 2017 Nov;31(11):2326-2335. doi: 10.1038/leu.2017.81. Epub 2017 Mar 10.

PMID:
28280275
12.

FLT3 inhibitors: clinical potential in acute myeloid leukemia.

Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J.

Onco Targets Ther. 2017 Feb 3;10:607-615. doi: 10.2147/OTT.S103790. eCollection 2017. Review.

13.

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.

Trias E, Ibarburu S, Barreto-Núñez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Díaz-Amarilla P, Cassina P, Martínez-Palma L, Moura IC, Beckman JS, Hermine O, Barbeito L.

J Neuroinflammation. 2016 Jul 11;13(1):177. doi: 10.1186/s12974-016-0620-9.

14.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Green AS, Maciel TT, Hospital MA, Yin C, Mazed F, Townsend EC, Pilorge S, Lambert M, Paubelle E, Jacquel A, Zylbersztejn F, Decroocq J, Poulain L, Sujobert P, Jacque N, Adam K, So JC, Kosmider O, Auberger P, Hermine O, Weinstock DM, Lacombe C, Mayeux P, Vanasse GJ, Leung AY, Moura IC, Bouscary D, Tamburini J.

Sci Adv. 2015 Sep 18;1(8):e1500221. doi: 10.1126/sciadv.1500221. eCollection 2015 Sep.

15.

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, Saland E, Decroocq J, Maciel TT, Lambert M, Poulain L, Hospital MA, Sujobert P, Joseph L, Chapuis N, Lacombe C, Moura IC, Demo S, Sarry JE, Recher C, Mayeux P, Tamburini J, Bouscary D.

Blood. 2015 Sep 10;126(11):1346-56. doi: 10.1182/blood-2015-01-621870. Epub 2015 Jul 17.

16.

The role of mast cells in cancers.

Maciel TT, Moura IC, Hermine O.

F1000Prime Rep. 2015 Jan 5;7:09. doi: 10.12703/P7-09. eCollection 2015. Review.

17.

HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.

Arlet JB, Ribeil JA, Guillem F, Negre O, Hazoume A, Marcion G, Beuzard Y, Dussiot M, Moura IC, Demarest S, de Beauchêne IC, Belaid-Choucair Z, Sevin M, Maciel TT, Auclair C, Leboulch P, Chretien S, Tchertanov L, Baudin-Creuza V, Seigneuric R, Fontenay M, Garrido C, Hermine O, Courtois G.

Nature. 2014 Oct 9;514(7521):242-6. doi: 10.1038/nature13614. Epub 2014 Aug 24.

PMID:
25156257
18.

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Dussiot M, Maciel TT, Fricot A, Chartier C, Negre O, Veiga J, Grapton D, Paubelle E, Payen E, Beuzard Y, Leboulch P, Ribeil JA, Arlet JB, Coté F, Courtois G, Ginzburg YZ, Daniel TO, Chopra R, Sung V, Hermine O, Moura IC.

Nat Med. 2014 Apr;20(4):398-407. doi: 10.1038/nm.3468. Epub 2014 Mar 23.

PMID:
24658077
19.

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Willems L, Jacque N, Jacquel A, Neveux N, Maciel TT, Lambert M, Schmitt A, Poulain L, Green AS, Uzunov M, Kosmider O, Radford-Weiss I, Moura IC, Auberger P, Ifrah N, Bardet V, Chapuis N, Lacombe C, Mayeux P, Tamburini J, Bouscary D.

Blood. 2013 Nov 14;122(20):3521-32. doi: 10.1182/blood-2013-03-493163. Epub 2013 Sep 6.

20.

[Regulation of erythropoiesis mediated by immunoglobulin A1].

Coulon S, Dussiot M, Grapton D, Rossignol J, Maciel TT, Benhamou M, Monteiro RC, Hermine O, Moura IC.

Med Sci (Paris). 2012 Aug-Sep;28(8-9):692-5. doi: 10.1051/medsci/2012288006. Epub 2012 Aug 22. French. No abstract available.

21.

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.

Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogné M, Moura IC, Monteiro RC.

J Exp Med. 2012 Apr 9;209(4):793-806. doi: 10.1084/jem.20112005. Epub 2012 Mar 26.

22.

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

Willems L, Chapuis N, Puissant A, Maciel TT, Green AS, Jacque N, Vignon C, Park S, Guichard S, Herault O, Fricot A, Hermine O, Moura IC, Auberger P, Ifrah N, Dreyfus F, Bonnet D, Lacombe C, Mayeux P, Bouscary D, Tamburini J.

Leukemia. 2012 Jun;26(6):1195-202. doi: 10.1038/leu.2011.339. Epub 2011 Dec 6.

PMID:
22143671
23.

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC.

Nat Med. 2011 Oct 23;17(11):1456-65. doi: 10.1038/nm.2462.

PMID:
22019886
24.

Pathologic calcification of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin.

Leroux-Berger M, Queguiner I, Maciel TT, Ho A, Relaix F, Kempf H.

J Bone Miner Res. 2011 Jul;26(7):1543-53. doi: 10.1002/jbmr.382.

25.

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.

Green AS, Chapuis N, Maciel TT, Willems L, Lambert M, Arnoult C, Boyer O, Bardet V, Park S, Foretz M, Viollet B, Ifrah N, Dreyfus F, Hermine O, Moura IC, Lacombe C, Mayeux P, Bouscary D, Tamburini J.

Blood. 2010 Nov 18;116(20):4262-73. doi: 10.1182/blood-2010-02-269837. Epub 2010 Jul 28.

PMID:
20668229
26.

Targeting bone morphogenetic protein signaling on renal and vascular diseases.

Maciel TT, Kempf H, Campos AH.

Curr Opin Nephrol Hypertens. 2010 Jan;19(1):26-31. doi: 10.1097/MNH.0b013e328332fc13. Review.

PMID:
19823085
27.

Disrupted cell cycle control in cultured endometrial cells from patients with endometriosis harboring the progesterone receptor polymorphism PROGINS.

D'Amora P, Maciel TT, Tambellini R, Mori MA, Pesquero JB, Sato H, Girão MJ, Guerreiro da Silva ID, Schor E.

Am J Pathol. 2009 Jul;175(1):215-24. doi: 10.2353/ajpath.2009.080966. Epub 2009 Jun 4.

28.

The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis.

Maciel TT, Melo RS, Campos AH.

J Vasc Res. 2009;46(4):325-32. doi: 10.1159/000189793. Epub 2009 Jan 10.

29.

Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis.

Achar E, Maciel TT, Collares CF, Teixeira VP, Schor N.

Kidney Int. 2009 Mar;75(6):596-604. doi: 10.1038/ki.2008.578. Epub 2008 Nov 26.

30.

Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model.

Maciel TT, Coutinho EL, Soares D, Achar E, Schor N, Bellini MH.

J Nephrol. 2008 Sep-Oct;21(5):753-60.

PMID:
18949731
31.

Gremlin promotes vascular smooth muscle cell proliferation and migration.

Maciel TT, Melo RS, Schor N, Campos AH.

J Mol Cell Cardiol. 2008 Feb;44(2):370-9. Epub 2007 Nov 12.

PMID:
18086474
32.

Endostatin expression in the murine model of ischaemia/reperfusion-induced acute renal failure.

Bellini MH, Coutinho EL, Filgueiras TC, Maciel TT, Schor N.

Nephrology (Carlton). 2007 Oct;12(5):459-65.

PMID:
17803469
33.

Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells.

Almeida WS, Maciel TT, Di Marco GS, Casarini DE, Campos AH, Schor N.

Kidney Int. 2006 Mar;69(6):974-80.

Supplemental Content

Loading ...
Support Center